Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Terminated 3 Withdrawn 1 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 697 Urinary Bladder Neoplasms 256 Carcinoma, Renal Cell 190 Kidney Neoplasms 94 Neoplasms 72 Carcinoma, Transitional Cell 69 Breast Neoplasms 66 Lung Neoplasms 38 Ovarian Neoplasms 37 Melanoma 37 Colorectal Neoplasms 37 Stomach Neoplasms 36 Non-Muscle Invasive Bladder Neoplasms 35 Neoplasm Metastasis 33 Pancreatic Neoplasms 31 Carcinoma, Non-Small-Cell Lung 29 Recurrence 26 Colonic Neoplasms 25 Uterine Cervical Neoplasms 20 Urologic Neoplasms 20 Testicular Neoplasms 20 Esophageal Neoplasms 20 Liver Neoplasms 18 Head and Neck Neoplasms 18 Disease 18 Wilms Tumor 17 Carcinoma, Hepatocellular 17 Endometrial Neoplasms 16 Sarcoma 15 Prostatic Hyperplasia 15

Interventions

enzalutamide 1 capivasertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Adenocarcinoma of the Prostate × Genitourinary × Clear all

NCT02525068 2018-08-08

RE-AKT

Institute of Cancer Research, United Kingdom

Phase 2 Unknown

Adenocarcinoma of the Prostate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡